Revamping hepatitis C global eradication efforts: towards simplified and enhanced screening, prevention, and treatment

被引：2
作者：
Pan, Calvin Q. [1 ,2 ]
Park, James S. [3 ,4 ,5 ]
机构：
[1] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou Med Res Inst Infect Dis, Dept Infect Dis, Guangzhou, Peoples R China
[2] NYU Grossman Sch Med, NYU Langone Hlth, Dept Med, Div Gastroenterol & Hepatol, New York, NY USA
[3] North Shore Univ Hosp, Dept Med, Div Hepatol, 300 Community Dr, Manhasset, NY 11030 USA
[4] Donald & Barbara Zucker Sch Med Hofstra Northwell, Hempstead, NY 11549 USA
[5] North Shore Univ Hosp, Northwell Transplant Inst, Northwell Ctr Liver Dis & Transplantat, Manhasset, NY 11030 USA
来源：
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 9卷
关键词：
Hepatitis elimination; hepatitis C virus care cascade (HCV care cascade); HCV management; 30 direct-acting antivirals (30 DAAs); adherence to therapy; VIRUS-INFECTION; UNITED-STATES;
D O I：
10.21037/tgh-23-104
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：6
相关论文
共 14 条
  • [1] Linkage to Care for Suburban Heroin Users with Hepatitis C Virus Infection, New Jersey, USA
    Akyar, Eda
    Seneca, Kathleen H.
    Akyar, Serra
    Schofield, Neal
    Schwartz, Mark P.
    Nahass, Ronald G.
    [J]. EMERGING INFECTIOUS DISEASES, 2016, 22 (05) : 907 - 909
  • [2] Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases- Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
    Bhattacharya, Debika
    Aronsohn, Andrew
    Price, Jennifer
    Lo Re, Vincent, III
    [J]. CLINICAL INFECTIOUS DISEASES, 2023,
  • [3] Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study
    Cunningham, Evan B.
    Amin, Janaki.
    Feld, Jordan J.
    Bruneau, Julie
    Dalgard, Olav
    Powis, Jeff
    Hellard, Margaret
    Cooper, Curtis
    Read, Phillip
    Conway, Brian
    Dunlop, Adrian J.
    Norton, Briana
    Litwin, Alain H.
    Hajarizadeh, Behzad
    Thurnheer, Maria Christine
    Dillon, John F.
    Weltman, Martin
    Shaw, David
    Bruggmann, Philip
    Gane, Edward
    Fraser, Chris
    Marks, Philippa
    Applegate, Tanya L.
    Quiene, Sophie
    Siriragavan, Sharmila
    Matthews, Gail V.
    Dore, Gregory J.
    Grebely, Jason
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2018, 62 : 14 - 23
  • [4] Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic
    Kaufman, Harvey W.
    Bull-Otterson, Lara
    Meyer, William A., III
    Huang, Xiaohua
    Doshani, Mona
    Thompson, William W.
    Osinubi, Ademola
    Khan, Mohammed A.
    Harris, Aaron M.
    Gupta, Neil
    Van Handel, Michelle
    Wester, Carolyn
    Mermin, Jonathan
    Nelson, Noele P.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2021, 61 (03) : 369 - 376
  • [5] Comparative efficacy of sofosbuvir-ribavirin versus sofosbuvir-daclatasvir for treatment of chronic hepatitis C in an area with limited NS5A inhibitor availability
    Kurniawan J.
    Gani R.A.
    Hasan I.
    Sulaiman A.S.
    Lesmana C.R.A.
    Jasirwan C.O.M.
    Kalista K.F.
    Nababan S.H.H.
    Zulkifly S.
    [J]. Indian Journal of Gastroenterology, 2018, 37 (6) : 520 - 525
  • [6] The Payer License Agreement, or "Netflix model," for hepatitis C virus therapies enables universal treatment access, lowers costs and incentivizes innovation and competition
    Matthews, David W.
    Coleman, Samantha
    Razavi, Homie
    Izaret, Jean-Manuel
    [J]. LIVER INTERNATIONAL, 2022, 42 (07) : 1503 - 1516
  • [7] Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication
    Mueller, Peter P.
    Chen, Qiushi
    Ayer, Turgay
    Nemutlu, Gizem S.
    Hajjar, Ali
    Bethea, Emily D.
    Peters, Mary Linton B.
    Lee, Brian P.
    Janjua, Naveed Z.
    Kanwal, Fasiha
    Chhatwal, Jagpreet
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 (01) : 55 - 62
  • [8] CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020
    Schillie, Sarah
    Wester, Carolyn
    Osborne, Melissa
    Wesolowski, Laura
    Ryerson, A. Blythe
    [J]. MMWR RECOMMENDATIONS AND REPORTS, 2020, 69 (02): : 1 - 17
  • [9] Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals
    Serper, Marina
    Evon, Donna M.
    Stewart, Paul W.
    Lok, Anna S.
    Amador, Jipcy
    Reeve, Bryce B.
    Golin, Carol E.
    Fried, Michael W.
    Reddy, K. Rajender
    Sterling, Richard K.
    Sarkar, Souvik
    Di Bisceglie, Adrian M.
    Lim, Joseph K.
    Nelson, David R.
    Reau, Nancy
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (04) : 1011 - 1020
  • [10] A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial
    Solomon, Sunil S.
    Wagner-Cardoso, Sandra
    Smeaton, Laura
    Sowah, Leonard A.
    Wimbish, Chanelle
    Robbins, Gregory
    Brates, Irena
    Scello, Christine
    Son, Annie
    Avihingsanon, Anchalee
    Linas, Benjamin
    Anthony, Donald
    Nunes, Estevao Portela
    Kliemann, Dimas A.
    Supparatpinyo, Khuanchai
    Kityo, Cissy
    Tebas, Pablo
    Bennet, Jaclyn Ann
    Santana-Bagur, Jorge
    Benson, Constance A.
    Van Schalkwyk, Marije
    Cheinquer, Nelson
    Naggie, Susanna
    Wyles, David
    Sulkowski, Mark
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (04): : 307 - 317
12